Gut microbiota and probiotics: Current status and their role in cancer therapeutics

Drug Development Research

Volumn 74, Issue 6, 2013, Pages 365-375

  Khan, Abdul Arif ^a   Khurshid, Mohsin ^a   Khan, Shahanavaj ^a   Alshamsan, Aws ^a,b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

cancer; cancer management; normal microflora; probiotics

Indexed keywords

BCG VACCINE; BETA GALACTOSIDASE; CARCINOGEN; FLUOROURACIL; PROBIOTIC AGENT; YOGHURT;

ANTIBIOTIC ASSOCIATED DIARRHEA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ATOPIC DERMATITIS; BACTERIAL LOAD; BIFIDOBACTERIUM; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BIFIDUM; BLADDER CANCER; BREAST CANCER; CANCER IMMUNOTHERAPY; CANCER PATIENT; CANCER PREVENTION; CANCER RISK; CANCER SURVIVAL; CANCER THERAPY; CELL ACTIVITY; CLOSTRIDIUM PERFRINGENS; COLON CANCER; CROHN DISEASE; DIET SUPPLEMENTATION; HEALTH STATUS; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INTESTINE FLORA; LACTIC ACID BACTERIUM; LACTOBACILLUS BULGARICUS; LACTOBACILLUS CASEI; LACTOBACILLUS JOHNSONII; LACTOBACILLUS PLANTARUM; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS SALIVARIUS; LACTOSE INTOLERANCE; METABOLOME; PROPIONIBACTERIUM FREUDENREICHII; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SACCHAROMYCES BOULARDII; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS SALIVARIUS;

EID: 84883867391     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.21087     Document Type: Review

References (96)

1. Allen SJ, Okoko B, Martinez E, Gregorio G, Dans LF,. 2004. Probiotics for treating infectious diarrhoea. Cochrane Database Syst Rev (2): CD003048.
2. Altonsy MO, Andrews SC, Tuohy KM,. 2010. Differential induction of apoptosis in human colonic carcinoma cells (Caco-2) by Atopobium, and commensal, probiotic and enteropathogenic bacteria: mediation by the mitochondrial pathway. Int J Food Microbiol 137: 190-203.
3. Angelakis E, Million M, Henry M, Raoult D,. 2011. Rapid and accurate bacterial identification in probiotics and yoghurts by MALDI-TOF mass spectrometry. J Food Sci 76: M568-M572.
4. Armuzzi A, Cremonini F, Ojetti V, Bartolozzi F, Canducci F, Candelli M, Santarelli L, Cammarota G, De Lorenzo A, Pola P, others. 2001. Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. Digestion 63: 1-7.
5. Asano M, Karasawa E, Takayama T,. 1986. Antitumor activity of Lactobacillus casei (LC 9018) against experimental mouse bladder tumor (MBT-2). J Urol 136: 719-721.
6. Balamurugan R, Janardhan HP, George S, Chittaranjan SP, Ramakrishna BS,. 2008. Bacterial succession in the colon during childhood and adolescence: molecular studies in a southern Indian village. Am J Clin Nutr 88: 1643-1647.
7. Baldwin C, Millette M, Oth D, Ruiz MT, Luquet FM, Lacroix M,. 2010. Probiotic Lactobacillus acidophilus and L. casei mix sensitize colorectal tumoral cells to 5-fluorouracil-induced apoptosis. Nutr Cancer 62: 371-378.
8. Biffi A, Coradini D, Larsen R, Riva L, Di Fronzo G,. 1997. Antiproliferative effect of fermented milk on the growth of a human breast cancer cell line. Nutr Cancer 28: 93-99.
9. Borchers AT, Selmi C, Meyers FJ, Keen CL, Gershwin ME,. 2009. Probiotics and immunity. J Gastroenterol 44: 26-46.
10. Borchert D, Sheridan L, Papatsoris A, Faruquz Z, Barua JM, Junaid I, Pati Y, Chinegwundoh F, Buchholz N,. 2008. Prevention and treatment of urinary tract infection with probiotics: review and research perspective. Indian J Urol 24: 139-144.
11. Boyle RJ, Robins-Browne RM, Tang ML,. 2006. Probiotic use in clinical practice: what are the risks? Am J Clin Nutr 83: 1256-1264; quiz 1446-1447.
12. Brigidi P, Vitali B, Swennen E, Bazzocchi G, Matteuzzi D,. 2001. Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea. Res Microbiol 152: 735-741.
13. Burns AJ, Rowland IR,. 2000. Anti-carcinogenicity of probiotics and prebiotics. Curr Issues Intest Microbiol 1: 13-24.
14. Castro WF, Cruz AG, Bisinotto MS, Guerreiro LM, Faria JA, Bolini HM, Cunha RL, Deliza R,. 2013. Development of probiotic dairy beverages: rheological properties and application of mathematical models in sensory evaluation. J Dairy Sci 96: 16-25.
15. Charteris WP, Kelly PM, Morelli L, Collins JK,. 1998. Development and application of an in vitro methodology to determine the transit tolerance of potentially probiotic Lactobacillus and Bifidobacterium species in the upper human gastrointestinal tract. J Appl Microbiol 84: 759-768.
16. Cho KM, Math RK, Islam SM, Lim WJ, Hong SY, Kim JM, Yun MG, Cho JJ, Yun HD,. 2009. Biodegradation of chlorpyrifos by lactic acid bacteria during kimchi fermentation. J Agric Food Chem 57: 1882-1889.
17. Cremonini F, Di Caro S, Covino M, Armuzzi A, Gabrielli M, Santarelli L, Nista EC, Cammarota G, Gasbarrini G, Gasbarrini A,. 2002. Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 97: 2744-2749.
18. de Vrese M, Stegelmann A, Richter B, Fenselau S, Laue C, Schrezenmeir J,. 2001. Probiotics-compensation for lactase insufficiency. Am J Clin Nutr 73 (2 Suppl): 421S-429S.
19. Escamilla J, Lane MA, Maitin V,. 2012. Cell-free supernatants from probiotic Lactobacillus casei and Lactobacillus rhamnosus GG decrease colon cancer cell invasion in vitro. Nutr Cancer 64: 871-878.
20. FAO/WHO. 2001. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Food and Agriculture Organization of the United Nations and World Health Organization Expert Consultation Report.
21. Fischer C, Altwein J,. 2007. [Statins and probiotics in the prevention of urologic diseases]. Urologe A 46: 622-627.
22. Foo NP, Ou Yang H, Chiu HH, Chan HY, Liao CC, Yu CK, Wang YJ,. 2011. Probiotics prevent the development of 1,2-dimethylhydrazine (DMH)-induced colonic tumorigenesis through suppressed colonic mucosa cellular proliferation and increased stimulation of macrophages. J Agric Food Chem 59: 13337-13345.
23. Gianotti L, Morelli L, Galbiati F, Rocchetti S, Coppola S, Beneduce A, Gilardini C, Zonenschain D, Nespoli A, Braga M,. 2010. A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients. World J Gastroenterol 16: 167-175.
24. Gill H, Prasad J,. 2008. Probiotics, immunomodulation, and health benefits. Adv Exp Med Biol 606: 423-454.
25. Gionchetti P, Rizzello F, Helwig U, Venturi A, Lammers KM, Brigidi P, Vitali B, Poggioli G, Miglioli M, Campieri M,. 2003. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 124: 1202-1209.
26. Gluck U, Gebbers JO,. 2003. Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumoniae, and beta-hemolytic streptococci). Am J Clin Nutr 77: 517-520.
27. Goldin BR, Gorbach SL,. 2008. Clinical indications for probiotics: an overview. Clin Infect Dis 46 (Suppl 2): S96-100; discussion S144-S151.
28. Gratz S, Taubel M, Juvonen RO, Viluksela M, Turner PC, Mykkanen H, El-Nezami H,. 2006. Lactobacillus rhamnosus strain GG modulates intestinal absorption, fecal excretion, and toxicity of aflatoxin B(1) in rats. Appl Environ Microbiol 72: 7398-7400.
29. Gupta P, Andrew H, Kirschner BS, Guandalini S,. 2000. Is lactobacillus GG helpful in children with Crohn's disease? Results of a preliminary, open-label study. J Pediatr Gastroenterol Nutr 31: 453-457.
30. Gupta V, Garg R,. 2009. Probiotics. Indian J Med Microbiol 27: 202-209.
31. Guslandi M, Mezzi G, Sorghi M, Testoni PA,. 2000. Saccharomyces boulardii in maintenance treatment of Crohn's disease. Dig Dis Sci 45: 1462-1464.
32. Harmsen HJ, Wildeboer-Veloo AC, Raangs GC, Wagendorp AA, Klijn N, Bindels JG, Welling GW,. 2000. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr 30: 61-67.
33. Haskard C, Binnion C, Ahokas J,. 2000. Factors affecting the sequestration of aflatoxin by Lactobacillus rhamnosus strain GG. Chem Biol Interact 128: 39-49.
34. Hatakka K, Savilahti E, Ponka A, Meurman JH, Poussa T, Nase L, Saxelin M, Korpela R,. 2001. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ 322: 1327.
35. Hatakka K, Holma R, El-Nezami H, Suomalainen T, Kuisma M, Saxelin M, Poussa T, Mykkanen H, Korpela R,. 2008. The influence of Lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp. shermanii JS on potentially carcinogenic bacterial activity in human colon. Int J Food Microbiol 128: 406-410.
36. Hickson M,. 2011. Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection. Ther Adv Gastroenterol 4: 185-197.
37. Hilton E, Kolakowski P, Singer C, Smith M,. 1997. Efficacy of lactobacillus GG as a diarrheal preventive in travelers. J Travel Med 4: 41-43.
38. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S,. 2000. Probiotics in the management of atopic eczema. Clin Exp Allergy 30: 1604-1610.
39. Isolauri E, Kirjavainen PV, Salminen S,. 2002. Probiotics: a role in the treatment of intestinal infection and inflammation? Gut 50 (Suppl 3): III54-III59.
40. Jalali M, Abedi D, Varshosaz J, Najjarzadeh M, Mirlohi M, Tavakoli N,. 2012. Stability evaluation of freeze-dried Lactobacillus paracasei subsp. tolerance and Lactobacillus delbrueckii subsp. bulgaricus in oral capsules. Res Pharm Sci 7: 31-36.
41. Jan G, Belzacq AS, Haouzi D, Rouault A, Metivier D, Kroemer G, Brenner C,. 2002. Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria. Cell Death Differ 9: 179-188.
42. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E,. 2001. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357: 1076-1079.
43. Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E,. 2003. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361: 1869-1871.
44. Kaur IP, Chopra K, Saini A,. 2002. Probiotics: potential pharmaceutical applications. Eur J Pharm Sci 15: 1-9.
45. Khan AA, Shrivastava A, Khurshid M,. 2012. Normal to cancer microbiome transformation and its implication in cancer diagnosis. Biochim Biophys Acta 1826: 331-337.
46. Kim Y, Lee D, Kim D, Cho J, Yang J, Chung M, Kim K, Ha N,. 2008. Inhibition of proliferation in colon cancer cell lines and harmful enzyme activity of colon bacteria by Bifidobacterium adolescentis SPM0212. Arch Pharm Res 31: 468-473.
47. Kim Y, Oh S, Yun HS, Kim SH,. 2010. Cell-bound exopolysaccharide from probiotic bacteria induces autophagic cell death of tumour cells. Lett Appl Microbiol 51: 123-130.
48. Kumar M, Kumar A, Nagpal R, Mohania D, Behare P, Verma V, Kumar P, Poddar D, Aggarwal PK, Henry CJ, others. 2010. Cancer-preventing attributes of probiotics: an update. Int J Food Sci Nutr 61: 473-496.
49. Kumar M, Nagpal R, Verma V, Kumar A, Kaur N, Hemalatha R, Gautam SK, Singh B,. 2013. Probiotic metabolites as epigenetic targets in the prevention of colon cancer. Nutr Rev 71: 23-34.
50. Kumar RS, Kanmani P, Yuvaraj N, Paari KA, Pattukumar V, Thirunavukkarasu C, Arul V,. 2012. Lactobacillus plantarum AS1 isolated from south Indian fermented food Kallappam suppress 1,2-dimethyl hydrazine (DMH)-induced colorectal cancer in male Wistar rats. Appl Biochem Biotechnol 166: 620-631.
51. Lawley TD, Walker AW,. 2013. Intestinal colonization resistance. Immunology 138: 1-11.
52. Le MG, Moulton LH, Hill C, Kramar A,. 1986. Consumption of dairy produce and alcohol in a case-control study of breast cancer. J Natl Cancer Inst 77: 633-636.
53. Lederberg J,. 2000. Infectious history. Science 288: 287-293.
54. Lee NK, Park JS, Park E, Paik HD,. 2007. Adherence and anticarcinogenic effects of Bacillus polyfermenticus SCD in the large intestine. Lett Appl Microbiol 44: 274-278.
55. Lidbeck A, Övervik E, Rafter J, Nord CE, Gustafsson J,. 1992. Effect of Lactobacillus acidophilus supplements on mutagen excretion in faeces and urine in humans. Microbial Ecol Health Dis 5: 59-67.
56. Lilly DM, Stillwell RH,. 1965. Probiotics: growth-promoting factors produced by microorganisms. Science 147: 747-748.
57. Limdi JK, O'Neill C, McLaughlin J,. 2006. Do probiotics have a therapeutic role in gastroenterology? World J Gastroenterol 12: 5447-5457.
58. Ljungh A, Wadstrom T,. 2006. Lactic acid bacteria as probiotics. Curr Issues Intest Microbiol 7: 73-89.
59. Marchand J, Vandenplas Y,. 2000. Micro-organisms administered in the benefit of the host: myths and facts. Eur J Gastroenterol Hepatol 12: 1077-1088.
60. Maroof H, Hassan ZM, Mobarez AM, Mohamadabadi MA,. 2012. Lactobacillus acidophilus could modulate the immune response against breast cancer in murine model. J Clin Immunol 32: 1353-1359.
61. Matto J, Malinen E, Suihko ML, Alander M, Palva A, Saarela M,. 2004. Genetic heterogeneity and functional properties of intestinal bifidobacteria. J Appl Microbiol 97: 459-470.
62. McFarland LV,. 2010. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol 16: 2202-2222.
63. McIntosh GH, Royle PJ, Playne MJ,. 1999. A probiotic strain of L. acidophilus reduces DMH-induced large intestinal tumors in male Sprague-Dawley rats. Nutr Cancer 35: 153-159.
64. Mego M, Koncekova R, Mikuskova E, Drgona L, Ebringer L, Demitrovicova L, Nemova I, Trupl J, Mardiak J, Koza I, others. 2006. Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Phase II study. Support Care Cancer 14: 285-290.
65. Naito S, Koga H, Yamaguchi A, Fujimoto N, Hasui Y, Kuramoto H, Iguchi A, Kinukawa N,. 2008. Prevention of recurrence with epirubicin and lactobacillus casei after transurethral resection of bladder cancer. J Urol 179: 485-490.
66. Nase L, Hatakka K, Savilahti E, Saxelin M, Ponka A, Poussa T, Korpela R, Meurman JH,. 2001. Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res 35: 412-420.
67. O'Mahony L, Feeney M, O'Halloran S, Murphy L, Kiely B, Fitzgibbon J, Lee G, O'Sullivan G, Shanahan F, Collins JK,. 2001. Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice. Aliment Pharmacol Ther 15: 1219-1225.
68. Oberreuther-Moschner DL, Jahreis G, Rechkemmer G, Pool-Zobel BL,. 2004. Dietary intervention with the probiotics Lactobacillus acidophilus 145 and Bifidobacterium longum 913 modulates the potential of human faecal water to induce damage in HT29clone19A cells. Br J Nutr 91: 925-932.
69. Ohashi Y, Nakai S, Tsukamoto T, Masumori N, Akaza H, Miyanaga N, Kitamura T, Kawabe K, Kotake T, Kuroda M, others. 2002. Habitual intake of lactic acid bacteria and risk reduction of bladder cancer. Urol Int 68: 273-280.
70. Osterlund P, Ruotsalainen T, Korpela R, Saxelin M, Ollus A, Valta P, Kouri M, Elomaa I, Joensuu H,. 2007. Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer: a randomised study. Br J Cancer 97: 1028-1034.
71. Pala V, Sieri S, Berrino F, Vineis P, Sacerdote C, Palli D, Masala G, Panico S, Mattiello A, Tumino R, others. 2011. Yogurt consumption and risk of colorectal cancer in the Italian European prospective investigation into cancer and nutrition cohort. Int J Cancer 129: 2712-2719.
72. Peters RK, Pike MC, Garabrant D, Mack TM,. 1992. Diet and colon cancer in Los Angeles County, California. Cancer Causes Control 3: 457-473.
73. Pool-Zobel BL, Neudecker C, Domizlaff I, Ji S, Schillinger U, Rumney C, Moretti M, Vilarini I, Scassellati-Sforzolini R, Rowland I,. 1996. Lactobacillus- and bifidobacterium-mediated antigenotoxicity in the colon of rats. Nutr Cancer 26: 365-380.
74. Preidis GA, Versalovic J,. 2009. Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology 136: 2015-2031.
75. Rachid M, Matar C, Duarte J, Perdigon G,. 2006. Effect of milk fermented with a Lactobacillus helveticus R389(+) proteolytic strain on the immune system and on the growth of 4T1 breast cancer cells in mice. FEMS Immunol Med Microbiol 47: 242-253.
76. Rafter J,. 2003. Probiotics and colon cancer. Best Pract Res Clin Gastroenterol 17: 849-859.
77. Rafter J,. 2004. The effects of probiotics on colon cancer development. Nutr Res Rev 17: 277-284.
78. Rafter J, Bennett M, Caderni G, Clune Y, Hughes R, Karlsson PC, Klinder A, O'Riordan M, O'Sullivan GC, Pool-Zobel B, others. 2007. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am J Clin Nutr 85: 488-496.
79. Rautava S, Kalliomaki M, Isolauri E,. 2002. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 109: 119-121.
80. Reddy BS, Rivenson A,. 1993. Inhibitory effect of Bifidobacterium longum on colon, mammary, and liver carcinogenesis induced by 2-amino-3- methylimidazo[4,5-f]quinoline, a food mutagen. Cancer Res 53: 3914-3918.
81. Reid G, Sanders ME, Gaskins HR, Gibson GR, Mercenier A, Rastall R, Roberfroid M, Rowland I, Cherbut C, Klaenhammer TR,. 2003. New scientific paradigms for probiotics and prebiotics. J Clin Gastroenterol 37: 105-118.
82. Rolfe RD,. 2000. The role of probiotic cultures in the control of gastrointestinal health. J Nutr 130 (2S Suppl): 396S-402S.
83. Rowland IR, Rumney CJ, Coutts JT, Lievense LC,. 1998. Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis 19: 281-285.
84. Saxelin M,. 2008. Probiotic formulations and applications, the current probiotics market, and changes in the marketplace: a European perspective. Clin Infect Dis 46 (Suppl 2): S76-S79; discussion S144-S151.
85. Shanahan F,. 2005. Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases I. Pathophysiological basis and prospects for probiotic therapy in inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 288: G417-G421.
86. Sheil B, Shanahan F, O'Mahony L,. 2007. Probiotic effects on inflammatory bowel disease. J Nutr 137 (3 Suppl 2): 819S-824S.
87. Siegel R, Naishadham D, Jemal A,. 2012. Cancer statistics, 2012. CA Cancer J Clin 62: 10-29.
88. Singh J, Rivenson A, Tomita M, Shimamura S, Ishibashi N, Reddy BS,. 1997. Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis 18: 833-841.
89. Soltan Dallal MM, Yazdi MH, Holakuyee M, Hassan ZM, Abolhassani M, Mahdavi M,. 2012. Lactobacillus casei ssp.casei induced Th1 cytokine profile and natural killer cells activity in invasive ductal carcinoma bearing mice. Iran J Allergy Asthma Immunol 11: 183-189.
90. Szajewska H, Kotowska M, Mrukowicz JZ, Armanska M, Mikolajczyk W,. 2001. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr 138: 361-365.
91. Takagi A, Matsuzaki T, Sato M, Nomoto K, Morotomi M, Yokokura T,. 2001. Enhancement of natural killer cytotoxicity delayed murine carcinogenesis by a probiotic microorganism. Carcinogenesis 22: 599-605.
92. Thirabunyanon M, Hongwittayakorn P,. 2013. Potential probiotic lactic acid bacteria of human origin induce antiproliferation of colon cancer cells via synergic actions in adhesion to cancer cells and short-chain fatty acid bioproduction. Appl Biochem Biotechnol 169: 511-525.
93. Verma A, Shukla G,. 2013. Probiotics Lactobacillus rhamnosus GG, Lactobacillus acidophilus suppresses DMH-induced procarcinogenic fecal enzymes and preneoplastic aberrant crypt foci in early colon carcinogenesis in sprague dawley rats. Nutr Cancer 65: 84-91.
94. Wollowski I, Ji ST, Bakalinsky AT, Neudecker C, Pool-Zobel BL,. 1999. Bacteria used for the production of yogurt inactivate carcinogens and prevent DNA damage in the colon of rats. J Nutr 129: 77-82.
95. Yazdi MH, Soltan Dallal MM, Hassan ZM, Holakuyee M, Agha Amiri S, Abolhassani M, Mahdavi M,. 2010. Oral administration of Lactobacillus acidophilus induces IL-12 production in spleen cell culture of BALB/c mice bearing transplanted breast tumour. Br J Nutr 104: 227-232.
96. Yazdi MH, Mahdavi M, Kheradmand E, Shahverdi AR,. 2012. The preventive oral supplementation of a selenium nanoparticle-enriched probiotic increases the immune response and lifespan of 4T1 breast cancer bearing mice. Arzneimittelforschung 62: 525-531.